Scientists at the University of Oxford have announced plans to begin human trials of a new Ebola vaccine in the United Kingdom, less than two months after the World Health Organization (WHO) declared the current outbreak in the Democratic Republic of Congo (DRC) a global public health emergency.
The Phase 1 trial will evaluate the safety and immune response of an experimental vaccine targeting the Bundibugyo strain of Ebola, a less common but deadly variant responsible for the ongoing outbreak in the DRC.